Clinical Observation Of Jiawei Wendan Decoction In Treating Adenoid Hypertrophy,Phlegm,Heat And Stasis Syndrome In Children

ObjectiveIn recent years,the incidence of adenoidal hypertrophy in children ha s been increasing.While affecting the physical and mental health and qual ity of life of children,it also causes parents’ anxiety and brings a large family burden.In this study,we observed the changes in symptoms and sig ns before and after treatment,objectively evaluated the therapeutic effect of Jiawei Wendan Decoction in treating children with adenoid hypertroph y,phlegm,heat and stasis syndrome,and explored its theoretical basis and pharmacology.It also provides aevidence for enriching the treatment meth ods of adenoid hypertrophy in children.MethodsFrom March 2019 to September 2019,the outpatient clinic of Director Xu Shuanghong who met the criteria of children with adenoid hypertrophy and phlegm heat stasis syndrome was randomly divided into treatment group and control group using SPSS26.0 software.The treatment group took Jiawei Wendan Decoction orally,and added or subtracted drugs according to different accompanied symptoms.The control group was given Mometasone Furoate Aqueous Nasal Spray and Montelukast sodium chewable tablets orally.Two month was a course of treatment,and the two groups were treated for two courses.Observe the changes in clinical symptoms,signs and examination resu Its of the two groups before treating,lmonth,2 months,and evaluate the ef fect of Jiawei Wendan Decoction on children with adenoid hypertrophy phlegm heat stasis syndrome.ResultsA total of 68 children who met the criteria for children with adenoid hypertrophy and phlegm-heat stasis syndrome were included.In terms of gender:35 male children(51.47%)and 33 female children(48.53%).In terms of age:6 children(8.82%)from 2 to 3 years old,53 children(77.94%)from 3 to 7 years old,9 patients(13.24%)from 7 to 18 years old.In ter ms of course:27 cases(39.71%)of children<6 months,34 cases(50.00%)of children from 6 to 12 months,and 7 cases(10.29%)of children>12 months.Randomly divided into 35 cases in the treatment group,33 cases in the control group,5 cases were eliminated in the treatment group during treatment,3 cases were eliminated in the control group,a total of 60 ef fective cases were obtained.There is no statistically significant difference between the two groups in general data(P>0.05).Comparison of clinical efficacy:After 2 months of treatment,the tre atment group recovered 2 cases(6.67%),markedly effective 12 cases(40.00%),effective 12 cases(40.00%),ineffective 4 cases(13.33%),the total effective rate was 86.67%;The control group cured 1 case(3.34%),mark edly effective 7 cases(23.33%),effective 10 cases(33.33%),ineffective 12 cases(40.00%),the total effective rate was 60.00%;the treatment group had higher efficiency,the difference is significant(P<0.05).Comparison of main symptoms:The children in the two groups had a decrease in sleep snoring,nasal congestion,open mouth breathing,and sleep quality in each group after treatment for 1 month and 2 months after tre atment,and the difference was significant(P<0.05);There was no significant difference in the individual scores of sleep snoring,nasal congesti on,mouth breathing,and sleep quality before treatment between the two groups of children(P>0.05).Compared with the control group,at 1 month of treatment,there was no significant difference in the improvement of the main symptoms of sleep snoring,nasal congestion,mouth breathing,and sleep quality(P>0.05).At 2 months of treatment,the treatment group was at There were significant differences in sleep snoring,mouth breathing,and sleep quality improvement(P<0.05),especially in sleep quality(P=0.000).However,there was no significant difference in nasal congestion(P=0.070).Comparison of minor symptoms:There was a significant difference in t he improvement of minor symptoms between the two groups of patients after 1 month of treatment and 2 months of treatment(P<0.05);the comparison between the 2 groups of children and the treatment of 2 groups of children There was no significant difference in the total score of previous minor symptoms(P>0.05).Compared with the control group,at 1 month of treat ment,there was no significant difference in the improvement of secondary symptoms in the treatment group(P>0.05),and at 2 months of treatment,there was a significant difference in the improvement of secondary symptoms in the treatment group(P<0.05 0.05).Comparison of the degree of adenoid hypertrophy under nasopharyngoscope:there was a significant difference in the improvement of adenoid hype rtrophy under nasopharyngeal between the two groups after 1 month of trea tment and 2 months after treatment(P<0.05);2 groups In comparison between the groups of children,there was no significant difference in the degree of adenoid hypertrophy under nasopharyngoscope before treatment in the two groups(P>0.05).Compared with the control group,the treatment group had significant differences in the improvement of adenoid hypertrophy under nasopharyngoscope at 1 month and 2 months of treatment(P<0.05).ConclusionJiawei Wendan Decoction can significantly improve the clinical symptoms of adenoid hypertrophy,phlegm,heat and stasis in children,shrink the hypertrophic adenoid,and significantly improve the sleep quality of children.The overall effect is quite satisfied.